Indefinite Delivery Contract SPE2DR25D2228

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D2911 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $999,999,999 and a performance period through December 2036. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) that will provide worldwide pharmaceutical support, including brand-name,...
The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036. The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide...
The federal contract IDV award SPE2DR25D2006 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, for a total potential value of $999,999,999.00 through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor...
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award SPE2DR25D3003 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies and equipment, to various Department of Defense (DoD) customers, the U.S. Coast Guard,...
The federal contract IDV award SPE2DR25D3010 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2026 and serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
The federal contract IDV award SPE2DR25D3007 is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract runs through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D7059 is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. This single-award contract runs through December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The federal contract IDV award SPE2DR25D1103 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $9,999,999,999, is for the provision of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense (DoD), the United States Coast Guard, and...

The federal contract IDV award SPE2DR25D2228 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $999,999,999 and runs through December 2036, providing a broad range of pharmaceutical products and medical supplies to support various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies globally.

The original solicitation, referenced as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple regional prime vendor contracts for providing worldwide pharmaceutical support. The procurement is an unrestricted, fully competitive Lowest Price Technically Acceptable (LPTA) acquisition, with the intent to award at least three different contractors across four geographic regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet). Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal operations and contingency requirements. The total estimated value for all regions and option periods is $30.3 billion.

Generated 6/6/25, 10:07 AM